retatrutide phase 2 results obesity nejm 2023 Weight Regain after Stopping Medications:⁣, ⁣, Clinician Editor-in-Chief Raja-Elie Abdulnour, MD, explains a recent meta-analysis that showed projected return to baseline weight within Weight Regain after Stopping Obesity

A C20 fatty di-acid moiety attached via a Glu2AEEA linker enables reversible serum albumin binding and extends the circulating half-life to approximately six days, supporting once-weekly research dosing protocols

If you want to learn more about how similar medications compare, check out the comparison of Retatrutide vs Tirzepatide for additional context

And if you're just starting a GLP-1 medication now, our First Week on GLP-1 guide walks you through day by day

This includes the cost of your provider visits, medication, supplies, and ongoing support.

A medication being codeveloped by Boehringer Ingelheim and Zealand Pharma is survodutide, which combines a GLP-1 agonist and glucagon

Lets get into the details of the retatrutide dosing schedule for weight loss: Starting dose Retatrutide is typically started at a low dose of 1 mg once weekly for the first 4 weeks